Marinus Pharmaceuticals | MRNS - Market Capitalization


Marinus Pharmaceuticals reported $457.9M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.8B 724M Mar/2026
ALKERMES USD 5.88B 1.26B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
Eisai JPY 1.42T 110.62B Mar/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Esperion Therapeutics USD 885M 351M Dec/2025
Gilead Sciences USD 172.99B 20.71B Mar/2026
Incyte USD 18.73B 660M Mar/2026
Neurocrine Biosciences USD 13.25B 890M Mar/2026
PTC Therapeutics USD 5.64B 460M Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Supernus Pharmaceuticals USD 2.98B 126M Mar/2026
UCB EUR 46.41B 13.94B Dec/2025
Vertex Pharmaceuticals USD 113.58B 1.44B Mar/2026